Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 17% ± 2% |
Insufficient scRNA-seq data for expression of KLHL15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 773.24 | 245 / 245 | 99% | 8.42 | 497 / 502 |
esophagus | 100% | 950.30 | 1444 / 1445 | 99% | 9.23 | 181 / 183 |
brain | 99% | 667.79 | 2623 / 2642 | 99% | 7.59 | 701 / 705 |
adrenal gland | 100% | 2062.40 | 258 / 258 | 99% | 13.18 | 227 / 230 |
lung | 100% | 812.02 | 576 / 578 | 99% | 6.96 | 1141 / 1155 |
thymus | 100% | 784.89 | 652 / 653 | 99% | 9.43 | 596 / 605 |
ovary | 100% | 1577.99 | 180 / 180 | 97% | 5.79 | 419 / 430 |
breast | 100% | 683.67 | 459 / 459 | 97% | 8.16 | 1089 / 1118 |
pancreas | 100% | 589.60 | 328 / 328 | 96% | 5.37 | 171 / 178 |
skin | 100% | 686.05 | 1800 / 1809 | 95% | 8.39 | 448 / 472 |
stomach | 100% | 1042.84 | 359 / 359 | 94% | 6.93 | 270 / 286 |
uterus | 100% | 862.99 | 170 / 170 | 94% | 7.06 | 432 / 459 |
intestine | 100% | 834.69 | 966 / 966 | 92% | 5.52 | 486 / 527 |
kidney | 100% | 439.76 | 89 / 89 | 90% | 5.80 | 809 / 901 |
bladder | 100% | 605.52 | 21 / 21 | 89% | 4.79 | 448 / 504 |
liver | 100% | 985.71 | 226 / 226 | 87% | 5.02 | 352 / 406 |
spleen | 100% | 670.00 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 976.43 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 640.61 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 819.62 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 576.60 | 839 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 5.19 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 93% | 5.63 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 93% | 6.06 | 74 / 80 |
peripheral blood | 82% | 657.37 | 765 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0071630 | Biological process | nuclear protein quality control by the ubiquitin-proteasome system |
GO_2000042 | Biological process | negative regulation of double-strand break repair via homologous recombination |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KLHL15 |
Protein name | Kelch-like protein 15 Alternative protein KLHL15 |
Synonyms | KIAA1677 hCG_1642367 HEL-S-305 |
Description | FUNCTION: Substrate-specific adapter for CUL3 E3 ubiquitin-protein ligase complex . Acts as an adapter for CUL3 to target the serine/threonine-protein phosphatase 2A (PP2A) subunit PPP2R5B for ubiquitination and subsequent proteasomal degradation, thus promoting exchange with other regulatory subunits . Acts as an adapter for CUL3 to target the DNA-end resection factor RBBP8/CtIP for ubiquitination and subsequent proteasomal degradation . Through the regulation of RBBP8/CtIP protein turnover, plays a key role in DNA damage response, favoring DNA double-strand repair through error-prone non-homologous end joining (NHEJ) over error-free, RBBP8-mediated homologous recombination (HR) . . |
Accessions | ENST00000689334.1 ENST00000692681.1 ENST00000693269.1 V9HWF1 ENST00000328046.8 Q96M94 L8EB72 A0A8I5QJW5 ENST00000685367.1 ENST00000684871.1 |